HMS Networks AB
4.2.2021 16:51:23 CET | Globenewswire | Press release
HMS Networks AB (publ) has on February 4, 2021 purchased 50,000 shares (ISIN SE0009997018) for a price of SEK 308.65 per share. HMS Networks’ holdings of own shares amounts to 204,916 after the repurchase. The total number of outstanding shares in the company is 46,818,868. The repurchase has been made on Nasdaq Stockholm.
For more information, please contact:
Staffan Dahlström, CEO HMS, +46 (0)35 17 29 01
Joakim Nideborn, CFO HMS, +46 (0)35 710 6983
HMS Networks AB (publ) is a market-leading provider of solutions in industrial information and communication technology (Industrial ICT). HMS develops and manufactures products under the Anybus®, Ixxat®, Ewon® and Intesis® brands. Development takes place at the headquarter in Halmstad and also in Ravensburg, Nivelles, Igualada, Wetzlar Buchen and Delft. Local sales and support are handled by branch offices in Germany, USA, Japan, China, Singapore, Italy, France, Spain, the Netherlands, India, UK, Sweden, South Korea and UAE, as well as through a worldwide network of distributors and partners. HMS employs over 700 people and reported sales of SEK 1,467 million in 2020. HMS is listed on the NASDAQ OMX in Stockholm, category Mid Cap, Information Technology.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ProMIS Neurosciences Inc.6.10.2026 13:05:00 CEST | Press release
ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer
OKYO Pharma LTD6.10.2026 13:00:00 CEST | Press release
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
Octave Intelligence plc6.10.2026 13:00:00 CEST | Press release
Octave to Report Third Quarter 2026 Financial Results on November 12
The Descartes Systems Group Inc6.10.2026 12:45:00 CEST | Press release
Descartes Unveils Next Step in Supply Chain AI with Agent Control Plane
Martela Corporation6.10.2026 12:45:00 CEST | Press release
Final results of Martela Corporation’s directed share issue
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
